Inkjet-printed “Mini-Pills” for preclinical studies

Anastasia Zakharyuta

by Anastasia Zakharyuta, Post-Doctoral Researcher, Boehringer Ingelheim Pharma GMBH Co & KG

This presentation will focus on the development of formulations for pre-clinical studies is attempted in two different forms, namely basic and complex release solid dosage formulations. The former dosage is aimed to provide an alternative to suspensions, as to minimize variability by improving stability and repeatability of the routine formulations.

The latter provides the complex formulations at the early stage of rodent studies, by combining different formulation mechanisms. The different design for such formulations is feasible with regard to the desired release profile and administration route.

Herein, printing procedures are established for solid dosage fabrication, through incorporation of a number of low molecular weight biodegradable polymers via piezo-actuated inkjet printing.

Continue reading “Inkjet-printed “Mini-Pills” for preclinical studies”

3D printing: when a disruptive technology meets the legal perspective – Stampa 3D: quando una tecnologia dirompente incontra la prospettiva legale

Licia Garotti

by Licia Garotti, Partner of the law firm Gattai, Minoli, Agostinelli & Partners

The 3D printing has been acclaimed as a disruptive technology, which is changing the scenario in many different sectors.

The most revolutionary implementation has been developed in life science and healthcare, leading to legal implications which are far from ordinary.

From the responsibility arising from the use of product obtained with 3d print, to commercial and data protection features, touching the aspects of intellectual property, a state of the art of the mostly relevant legal profiles will take shape.

Continue reading “3D printing: when a disruptive technology meets the legal perspective – Stampa 3D: quando una tecnologia dirompente incontra la prospettiva legale”

Beyond bioprinting: on the eve of major changes in biotechnology and modern medicine

Pawel Slusarczyk

by Pawel Slusarczyk, President of the Board, CD3D Sp. z o.o.

  1. Introduction: short history of CD3D and The Open Bioprinting Cluster
  2. The historical approach: the development of the 3D printing industry and perspectives for the development of the bioprinting market
  3. Three pillars of technology development: the meaning of hardware, materials and software for creation of new kind of medical applications

Program: https://3dmedicalconference.com/program/

Continue reading “Beyond bioprinting: on the eve of major changes in biotechnology and modern medicine”

3D printing in Medicine. A new competence of Radiology?

Carmelo G. Puglisi

presented by Carmelo G. Puglisi, Medical Doctor, Radiologist, Arnas Garibaldi Catania

I will talk about the new scenarios in Medicine, focusing on the all-days cases that 3d printing applied to clinical needs can resolve. Will expose also my experience as a Medical Doctor , Radiologist, using 3D printing in selected cases for the pre-surgery planning .

program: https://3dmedicalconference.com/program/

Continue reading “3D printing in Medicine. A new competence of Radiology?”

SISMA will exhibit at 3D Medical Conference & Expo

sisma

SISMA is Silver Partner of the 3D Medical Expo during 3D Medical Conference 2019

SISMA S.p.A.
High precision manufacturing solutions, machinery and laser systems.

SISMA is a worldwide reference in the design and production of extremely high precision machinery and laser systems. Established in 1961, today SISMA can count on an extensive experience with more than 130 different models of automatic chain making machines.

Continue reading “SISMA will exhibit at 3D Medical Conference & Expo”

Simulation of Additive Manufacturing for medical applications – Current capabilities, benefits and open challenges

Patrick Mehmert

by Patrick Mehmert, Product Manager Additive Manufacturing, Simufact Engineering GmbH

Simulation of additive manufacturing processes gets more and more powerful and widespread in industrial applications. Also for medical applications the simulation of the production before the real print offers valuable benefits. Manufacturing problems can be identified in advance and countermeasures developed before a print fails. For geometrical critical applications the distortion prediction and compensation is very helpful.

Continue reading “Simulation of Additive Manufacturing for medical applications – Current capabilities, benefits and open challenges”

3D Bioprinting: use of Polycaprolactone in clinical and research biomedical applications

Andrea Del Fattore

duo presentation by

Andrea Del Fattore, Head of the Bone Physiopathology Group, Bambino Gesù Children’s Hospital, Rome, Italy

& Luca Borro, 3D Specialist, 3D Biomedica Advanced Modeling and Printing Technician, Bambino Gesù Children’s Hospital, Rome, Italy

Bioprinting is a technology that could revolutionize the biomedical field. It has already been used to engineer constructs that mimic aspects of the anatomical and structural complexity, allowing the production of perfectly functional and “biologically active” patient-specific parts.

One of the most important challenges of bioprinting is the identification of biomaterials that have adequate biocompatibility and biodegradability features to be used in clinical use in humans.

In this session we will describe some applications of 3D Bioprinting of Polycaprolactone in clinical applications and in research contexts.

Continue reading “3D Bioprinting: use of Polycaprolactone in clinical and research biomedical applications”

3D Bioprinting: use of Polycaprolactone in clinical and research biomedical applications

Luca Borro

duo presentation by

Luca Borro, 3D Specialist, 3D Biomedica Advanced Modeling and Printing Technician, Bambino Gesù Children’s Hospital, Rome, Italy

& Andrea Del Fattore, Head of the Bone Physiopathology Group, Bambino Gesù Children’s Hospital, Rome, Italy

Bioprinting is a technology that could revolutionize the biomedical field. It has already been used to engineer constructs that mimic aspects of the anatomical and structural complexity, allowing the production of perfectly functional and “biologically active” patient-specific parts.

One of the most important challenges of bioprinting is the identification of biomaterials that have adequate biocompatibility and biodegradability features to be used in clinical use in humans.

Continue reading “3D Bioprinting: use of Polycaprolactone in clinical and research biomedical applications”

A novel 3D printing platform and materials for bone scaffolds

Alessandro Patelli

by Alessandro Patelli, University of Padova

The presentation will cover the developments of the H2020 FAST project focused on the development of a novel 3D printer able to perform gradients while printing and at the same time to functionalize the surface by atmospheric pressure plasma. Coatings and novel nano composites materials based on PEOT/PBT will be presented.

Program: https://3dmedicalconference.com/program/

Continue reading “A novel 3D printing platform and materials for bone scaffolds”